Real-world outcomes of PD-L1 inhibitors combined with thoracic radiotherapy in the first-line treatment of extensive stage small cell lung cancer

BACKGROUND: The CREST study showed that the addition of thoracic radiotherapy (TRT) could improve the survival rate in patients with extensive stage small cell lung cancer (ES-SCLC), but whether TRT can bring survival benefit in the era of immunotherapy remains controversial. This study aimed to exp...

Descripción completa

Detalles Bibliográficos
Autores principales: Peng, Jianfeng, Zhang, Lemeng, Wang, Liping, Feng, Hui, Yao, Dongmei, Meng, Rui, Liu, Xiaomei, Li, Xiaohua, Liu, Ningbo, Tan, Bingxu, Huang, Zhaoqin, Li, Shanshan, Meng, Xiangjiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10320989/
https://www.ncbi.nlm.nih.gov/pubmed/37403111
http://dx.doi.org/10.1186/s13014-023-02308-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10320989/
https://www.ncbi.nlm.nih.gov/pubmed/37403111
http://dx.doi.org/10.1186/s13014-023-02308-2

Ejemplares similares